Page last updated: 2024-10-23

bumetanide and Muscle Spasticity

bumetanide has been researched along with Muscle Spasticity in 1 studies

Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Research Excerpts

ExcerptRelevanceReference
"Current anti-spastic medication significantly compromises motor recovery after spinal cord injury (SCI), indicating a critical need for alternative interventions."1.91Bumetanide increases postsynaptic inhibition after chronic SCI and decreases presynaptic inhibition with step-training. ( Bilchak, J; Caron, G; Côté, MP, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Caron, G1
Bilchak, J1
Côté, MP1

Other Studies

1 other study available for bumetanide and Muscle Spasticity

ArticleYear
Bumetanide increases postsynaptic inhibition after chronic SCI and decreases presynaptic inhibition with step-training.
    The Journal of physiology, 2023, Volume: 601, Issue:8

    Topics: Animals; Bumetanide; Chlorides; Motor Neurons; Muscle Spasticity; Rats; Spinal Cord; Spinal Cord Inj

2023